These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cephaloridine and cephalothin comparative in vitro evaluation. Perkins RL; Saslaw S; Hackett J Am J Med Sci; 1967 Mar; 253(3):293-9. PubMed ID: 4381476 [No Abstract] [Full Text] [Related]
4. [In vitro and in vivo antibacterial activity of cephapirin (author's transl)]. Mitsuhashi S; Yaginuma S; Ono H; Kurashige S Jpn J Antibiot; 1974 Apr; 27(2):152-6. PubMed ID: 4211466 [No Abstract] [Full Text] [Related]
5. In vitro studies with Ciba 36278-Ba, a new cephalosporin derivative. Russell AD Microbios; 1972 Dec; 6(24):221-30. PubMed ID: 4487949 [No Abstract] [Full Text] [Related]
6. [Oral antibiotics of the cephalosporin C group. Basic studies on cephachlozine]. Nakazawa S; Seta R; Todo Y; Sumihiro K; Nagase K Jpn J Antibiot; 1968 Dec; 21(6):331-5. PubMed ID: 4887884 [No Abstract] [Full Text] [Related]
7. [Study on the dynamics of antimicrobial agents in vivo--cephaloridine and cephalothin]. Kitamoto O; Fukaya K; Wajima T J Antibiot B; 1965 Dec; 18(6):443-6. PubMed ID: 5296407 [No Abstract] [Full Text] [Related]
8. [Basic and clinical studies on cephalosporin C antibiotics]. Kawamori Y; Tanaka S; Mitsuse S; Furuta T; Tomimatsu S J Antibiot B; 1965 Dec; 18(6):447-9. PubMed ID: 5296408 [No Abstract] [Full Text] [Related]
9. Antimicrobial studies in vitro with cephacetrile, a new cephalosporin derivative. Knüsel F; Konopka EA; Gelzer J; Rosselet A Arzneimittelforschung; 1974 Sep; 24(9b):1451-5. PubMed ID: 4215433 [No Abstract] [Full Text] [Related]
10. [Study on synthetic cephalosporin C]. Aoyama S; Moriguchi S; Takano M; Goto Y; Kawaguchi H J Antibiot B; 1965 Dec; 18(6):450-3. PubMed ID: 5296409 [No Abstract] [Full Text] [Related]
11. [Fundamental study on the antibacterial activity of cephaloridine]. Okubo N; Kobayashi F J Antibiot B; 1966 Apr; 19(1):21-7. PubMed ID: 5338400 [No Abstract] [Full Text] [Related]
12. Cephaloridine: antimicrobial activity and pharmacologic behavior. Kaplan K; Reisberg BE; Weinstein L Am J Med Sci; 1967 Jun; 253(6):667-74. PubMed ID: 4381751 [No Abstract] [Full Text] [Related]
13. [Bacteriological and pharmacological properties of new cephalosperine antibiotics. II. Cephaloridine]. Naumann P Arzneimittelforschung; 1967 Apr; 17(4):469-81. PubMed ID: 4386771 [No Abstract] [Full Text] [Related]
14. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin. Hsieh WC; Ho SW Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210 [TBL] [Abstract][Full Text] [Related]
16. [Experimental evaluation of the new cephalosporin antibiotic cephacetrile]. Kradolfer F; Ahrens T; Gelzer J; Vischer W; Zimmermann W Arzneimittelforschung; 1974 Sep; 24(9b):1446-51. PubMed ID: 4154769 [No Abstract] [Full Text] [Related]
17. Sensitivity of penicillinase-forming strains of Staphylococcus aureus and of their penicillinase-negative variants to cephaloridine, cephalothin, methicillin, and benzylpenicillin. Hewitt JH; Parker MT J Clin Pathol; 1968 Jan; 21(1):75-84. PubMed ID: 5188489 [TBL] [Abstract][Full Text] [Related]
18. Observations on the mode of action of cefoxitin. Onishi HR; Zimmerman SB; Stapley EO Ann N Y Acad Sci; 1974 May; 235(0):406-25. PubMed ID: 4604846 [No Abstract] [Full Text] [Related]
19. [Microbiological evaluation of a new synthetic cephalosporin, cephapirin (author's transl)]. Nakazawa S; Otsuki M; Kida K; Sakamichi T; Tanaka S Jpn J Antibiot; 1974 Apr; 27(2):164-73. PubMed ID: 4152697 [No Abstract] [Full Text] [Related]
20. In-vitro susceptibility of Mycobacterium fortuitum and related strains to cephalosporins. Haas H; Michel J; Sacks TG J Med Microbiol; 1973 May; 6(2):141-5. PubMed ID: 4488467 [No Abstract] [Full Text] [Related] [Next] [New Search]